Artax Biopharma Closes Financing To Advance Clinical Stage First-In-Class Oral Immunomodulator To Treat T Cell-Mediated Diseases
Round Type
Funding Round
CambridgeBiotechnologyDescription
Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated pathologies, today announces the close of a $26 million financing round to develop AX-158, the Company's first oral small molecule immunomodulating agent. New investors, Eli Lilly and Company and Sound Bioventures, participated alongside existing investors Advent Life Sciences, Columbus Venture Partners, Belinda Termeer and other Company shareholders.
Quick answer
Artax Biopharma raised an undisclosed amount in a Funding Round round, dated May 11, 2022. Artax Biopharma is based in Cambridge, Massachusetts, United States.
- How much did Artax Biopharma raise?
- Artax Biopharma raised an undisclosed amount in a Funding Round round on May 11, 2022.
- What does Artax Biopharma do?
- Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases.
- Where is Artax Biopharma based and how big is it?
- Artax Biopharma is based in Cambridge, Massachusetts, United States. Fundz records about 13 employees.
- Who are the decision-makers at Artax Biopharma?
- Fundz holds 1 contact at Artax Biopharma, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Artax Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Monod Bio, Inc. raised $24M on June 24, 2022.
- Inspirna raised $55M on June 24, 2022.
- Amprion raised $11M on June 24, 2022.
- sovaSage Inc. raised $4.3M (Seed) on June 24, 2022.
- CHARM Therapeutics raised $37M on June 24, 2022.
- RCE Technologies raised $20K on June 23, 2022.
Who to call at Artax Biopharma, and when
A new round usually means Artax Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Artax Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Artax Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Artax Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Artax Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Artax Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.